Floatz logo

URSODEOXYCHOLIC ACID

Hepatitis, Toxic

Taipei Veterans General Hospital, TaiwanSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Hepatitis, Toxic cohort.

Asset / SponsorPhaseRating
Levocarnitine
Children's Hospital of Orange County
Early Phase 1C
Palbociclib
University of Milano Bicocca
D
Abemaciclib
University of Milano Bicocca
D
Ribociclib
University of Milano Bicocca
D
Silymarin
Tanta University
Phase 2/3NR
mt2004
Xi'An Aolitai Pharmaceutical Technology Co Ltd
Phase 2NR

Same molecule, other indications

URSODEOXYCHOLIC ACID is also rated in:

primary biliary cholangitisDormant
A
Indicative ·
82 / 100
View asset →
Nonalcoholic Steatohepatitis (NASH)Dormant
BBB
Indicative ·
74 / 100
View asset →
cirrhosis of liverDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →